abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH) Announce an Additional 20% Increase in Distribution Rates Representing a 50% Increase Since January 2024
abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH), (collectively, the "Funds") each, a closed-end management investment company, announced today its Board of Trustees (each a "Board" and collectively, the "Boards") have approved an increase in each Fund's respective annualized distribution rate on NAV from 10% to 12%. Notably, HQH and HQL had previously announced distribution increases in February 2024, which increased the...
Read more








